Effect in a rat model of heparinized peritoneal dialysis catheters on bacterial colonization and the healing of the exit site.
We performed a prospective, double-blind, randomized study to evaluate whether stable surface heparinization of silicone peritoneal dialysis (PD) catheters prevents bacterial colonization or biofilm formation and improves healing of the exit site. Heparinized catheters were implanted in 20 Sprague-Dawley rats (group H) and non heparinized catheters in another 20 (group C). The PD catheters, constructed of silicon tubing with two polyester cuffs, were patterned after the standard Tenckhoff catheter. A covalent multipoint method of attachment onto polymeric surfaces was used for stable, permanent chemical immobilization of heparin on the PD catheter. Dialysis exchanges (25-mL instillation volume) were performed twice daily for 4 weeks through the permanent catheter. Prophylactic antibiotics were not used. The exit sites were evaluated at 2-week intervals. The extent of biofilm coverage on the intraperitoneal portion of the catheter (obtained at the end of the experiment) was assessed, and sonicated fluid from the catheter tip was cultured for evaluating bacterial colonization of the catheter. Exit-site scores in group H were lower than in group C (p = 0.052) at the end of week 4. Bacterial colonization tended to be less common in group H [2 of 12 catheters (17%)] than in group C [8 of 15 catheters (53%); p = 0.058], but the extent of biofilm, the peritonitis rate, and the inflammation score of tissue adjacent to the cuff were not different between the groups. Those data suggest that heparinized PD catheters can be a practical approach to the prevention of bacterial colonization and can improve healing of the exit site.
Kim
Y L
YL
Department of Internal Medicine, School of Medicine, Kyungpook National University, Taegu, South Korea. ylkim@knu.ac.kr
Cho
S
S
Kim
J C
JC
Cho
D K
DK
Kim
Y J
YJ
Larm
O
O
Mathiesen
T
T
Lindholm
B
B
Bergström
J
J
D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage*; D018441:Biofilms / Q000254:growth & development*; D002408:Catheters, Indwelling / Q000009:adverse effects / Q000382:microbiology*; D006493:Heparin / Q000008:administration & dosage*; D008297:Male; D010530:Peritoneal Dialysis / Q000009:adverse effects / Q000295:instrumentation*; D010538:Peritonitis / Q000209:etiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012825:Silicon; D013530:Surgical Wound Infection
D000925:Anticoagulants; D006493:Heparin; D012825:Silicon